Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H3JH
|
||||
Former ID |
DIB006117
|
||||
Drug Name |
CGI-1316
|
||||
Synonyms |
CGI-1316; CGI-1746; CGI-2233; CGI-2815; CGI-3130; CGI-560; CGI-676; Btk inhibitors (autoimmune disease/inflammatory disease); Btk inhibitors (autoimmune disease/inflammatory disease), CGI Pharmaceuticals; Btk inhibitors (autoimmune disease/inflammatory disease), Cellular Genomics; Btk inhibitors (autoimmune disease/inflammatory disease), Gilead
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Autoimmune diabetes [ICD10:E08-E13] | Investigative | [542950] | ||
Company |
CGI Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C34H37N5O4
|
||||
InChI |
InChI=1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-13-25(14-10-23)34(2,3)4)29-21-38(5)33(42)30(36-29)35-26-15-11-24(12-16-26)32(41)39-17-19-43-20-18-39/h6-16,21H,17-20H2,1-5H3,(H,35,36)(H,37,40)
|
||||
InChIKey |
JIFCFQDXHMUPGP-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Tyrosine-protein kinase BTK | Target Info | Inhibitor | [543527] | |
PANTHER Pathway | B cell activation | ||||
PathWhiz Pathway | Fc Epsilon Receptor I Signaling in Mast Cells | ||||
Reactome | MyD88:Mal cascade initiated on plasma membrane | ||||
Regulation of actin dynamics for phagocytic cup formation | |||||
DAP12 signaling | |||||
FCERI mediated Ca+2 mobilization | |||||
MyD88 deficiency (TLR2/4) | |||||
IRAK4 deficiency (TLR2/4) | |||||
RHO GTPases Activate WASPs and WAVEs | |||||
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.